(plated) Skin Science: The Biotech Brand Redefining Longevity Beauty

NEW YORK, NY – February 24, 2026 – As the beauty industry’s elite gather for the TD Cowen “Glowing Ahead Summit,” the conversation isn’t just about new shades of lipstick or moisturizing creams. Instead, the focus is on a deeper, more fundamental question: Can science truly turn back the clock on skin aging? One company, Rion Aesthetics, believes it has the answer, and it’s placing its breakout brand, (plated) Skin Science, at the center of this paradigm shift.

Alisa Lask, CEO of Rion Aesthetics, is set to take the stage today to discuss the meteoric rise of (plated), a brand that has quickly become a focal point in the burgeoning field of regenerative aesthetics. The company’s press release touts it as the “fastest-growing professional-grade skincare brand” and the “#1 dermatologist recommended exosome skincare brand.” While such claims are often part of a standard marketing playbook, they point to a significant undercurrent transforming the multi-billion-dollar beauty landscape: the move from cosmetic cover-ups to biotech-driven cellular repair.

The Cellular Messengers

At the heart of (plated) Skin Science’s appeal is a technology that sounds like it was lifted from a futuristic novel: platelet-derived exosomes. Exosomes are microscopic vesicles, thousands of times smaller than a human cell, that act as nature's own intercellular mail carriers. They shuttle vital cargo—proteins, lipids, and genetic material like mRNA—between cells, instructing them on how to behave, repair, and regenerate.

For decades, scientists have studied their role in healing and disease. Now, the beauty industry is harnessing their potential for skin rejuvenation. Rion Aesthetics’ proprietary Renewosome® Technology, born from over 20 years of research by physician-scientists at the Mayo Clinic’s prestigious Van Cleve Cardiac Regenerative Medicine Program, isolates and purifies exosomes derived from ethically sourced human platelets. The brand claims this process preserves the integrity and potency of these powerful messengers, delivering a concentrated blend of growth factors and nutrients that support the skin’s natural renewal processes.

This scientific approach represents a departure from traditional “anti-aging” philosophies. Instead of merely hydrating the skin’s surface or temporarily plumping fine lines, the goal of regenerative beauty is to support long-term skin health at a biological level. It’s a concept often referred to as “skin longevity”—a focus on enhancing the skin’s resilience and vitality over a lifetime, rather than just fighting a losing battle against wrinkles. By targeting cellular communication, brands like (plated) are promising not just a cosmetic effect, but a functional improvement in the skin's appearance, from reducing redness to improving texture and luminosity.

From Lab Bench to Market Leader

The transition from a complex scientific concept to a commercial success story is a notoriously difficult path. Yet, Rion Aesthetics appears to be navigating it with remarkable speed. The company cites independent research from Guidepoint Qsight, a firm that tracks point-of-sale data, to claim that (plated) captured the largest share of the professional-grade skincare market's year-over-year expansion, effectively becoming the primary engine of category growth.

This commercial acceleration is no accident. It’s the result of a deliberate strategy spearheaded by CEO Alisa Lask, an industry veteran with a formidable track record at giants like Galderma and Allergan. The strategy hinges on two key pillars: scientific validation and professional endorsement.

Rather than launching directly to consumers with a massive marketing campaign, (plated) focused on the professional channel—the dermatologists, plastic surgeons, and medical aestheticians who guide patient skincare choices. This approach allows the brand to build credibility from the ground up, leveraging the trust that exists between a physician and their patient. By becoming a staple for post-procedure care and a recommended part of a daily regimen, the brand has cultivated an army of expert advocates.

This focus on clinical efficacy has resonated in a market that is growing increasingly sophisticated. Today’s consumers are more informed and skeptical of marketing fluff. They demand transparency and results, and the professional-grade market, valued at over $12 billion globally, is booming as a result. By positioning itself at the intersection of biotechnology and beauty, (plated) is not just selling a product; it’s selling scientific credibility as the ultimate luxury.

Promise and Precaution

Despite the excitement, the world of exosome skincare is not without its complexities and controversies. The technology is so new that the regulatory framework is still catching up, creating a gray area that both innovators and consumers must navigate with care. A critical point often lost in the marketing buzz is that the U.S. Food and Drug Administration (FDA) has not approved any exosome products for cosmetic or therapeutic use.

In fact, the FDA classifies exosomes as biologics, subjecting them to the same rigorous approval process as drugs. The agency has issued public safety warnings about clinics offering unapproved exosome treatments, particularly injectables, and has sent warning letters to manufacturers making explicit disease-treating or tissue-regeneration claims that would classify their topical products as unapproved drugs.

This regulatory landscape presents a significant challenge. While topical application is generally considered far lower risk than injection, the line between a cosmetic claim (e.g., “improves the appearance of skin”) and a drug claim (e.g., “regenerates tissue”) can be thin. Rion Aesthetics appears to be acutely aware of this tightrope. The company emphasizes its adherence to safety standards, its use of FDA-approved platelet sources for its manufacturing process, and its commitment to clinical evidence.

To that end, the brand has invested in research to substantiate its claims. A 2022 study on the (plated) Intensive Repair Serum, published in the peer-reviewed Aesthetic Surgery Journal, demonstrated statistically significant improvements in skin redness, wrinkles, and luminosity over six weeks. By publishing in credible scientific journals and aligning with respected institutions like the Mayo Clinic, the company is actively working to build a fortress of scientific legitimacy around its technology, differentiating itself from less scrupulous players in a nascent market.

The New Face of Skincare

The rise of (plated) Skin Science and the broader regenerative beauty movement signals a fundamental change in our relationship with skincare. The focus is shifting from a reactive battle against the signs of aging to a proactive, long-term strategy for maintaining skin health and vitality. It reflects a deeper cultural trend that values wellness, authenticity, and science-backed solutions over quick fixes.

For consumers, this means the beauty counter is beginning to look more like a laboratory. Ingredients lists are becoming more complex, and brands are increasingly expected to provide clinical data to support their promises. The endorsement of a trusted dermatologist or aesthetician is becoming more valuable than that of a celebrity influencer. This evolution is forcing the entire industry to raise its standards, investing in research and development to create products that deliver measurable, lasting results.

The TD Cowen summit’s theme, “Beauty’s Evolution & Longevity as Luxury,” perfectly encapsulates this moment. The new luxury in beauty is not about opulent packaging or an extravagant price tag, but about access to cutting-edge, scientifically validated technology that supports the body’s own innate potential. As companies like Rion Aesthetics continue to push the boundaries of what’s possible, they are not just creating new products; they are pioneering a future where the line between skincare and healthcare becomes increasingly blurred.